503Pharma Weekly Compounding Pharmacy Roundup

1. Eli Lilly’s Lawsuit Against Strive Pharmacy Dismissed

A federal judge dismissed Eli Lilly’s case against Strive Pharmacy over compounded tirzepatide marketing, citing lack of jurisdiction (filed in Delaware, Strive based in Arizona). Judge Bibas noted, “Our legal system rewards innovative drug development, not innovative jurisdictional theories.” Lilly may refile in Arizona.

• Impact: Temporary win for compounding pharmacies, but expect ongoing IP battles.

• Source: https://news.bloomberglaw.com/ip-law/judge-drops-eli-lillys-suit-over-compounded-zepbound-mounjaro

2. NCPA 2025 Convention Preview: Focus on AI and Independent Resilience (Oct 12)

The National Community Pharmacists Association's annual event (Oct 18-21, New Orleans) spotlights AI in pharmacy, PBM fights, and growth strategies. Nearly 19,000 independents represent 35% of US retail pharmacies.

• Why It Matters: Key networking for compounding pros amid consolidation.

• Call to Action: Register for sessions on regulatory updates.

• Source:

  • Conference Preview: NCPA 2025 Annual Convention & Expo

  • NCPA 2024: In Spite of Challenges, Independent Pharmacies Are Continuing to Serve Patients

3. Stress-Free, Efficient Compliance Training

Tired of manual training tracking, compliance gaps, and dreading state board inspections? 503Pharma is launching CompoundLearn - the first Learning Management System (LMS) built specifically for compounding pharmacies. Join our waitlist for exclusive early access!

What you get:

• Never fail another inspection - Automated USP 795/797 documentation and training content with real-world scenarios

• Eliminate spreadsheet hell - Real-time dashboard shows exactly who needs what training when

• Stop losing sleep over deadlines - Automated reminders and certificate renewals

Request Free Compounding Formulas

✉️ That’s your 503Pharma weekly digest. Our mission is to keep compounding professionals informed, prepared, and ahead of the curve.